Note: Ingredients listed on restricted chemical lists
EC/CAS
68476-86-8
Name of the chemical
Petroleum gases, liquefied, sweetened
Concentration
N/A
EC/CAS
110-54-3
Name of the chemical
n-Hexan (790/2009)
Concentration
N/A
EC/CAS
64742-89-8
Name of the chemical
Solvent naphtha (petroleum), light aliph
Concentration
N/A
General Information
Product name
HIGH TACK SPRAY-A-GASKET SEALANT 4 OZ
1.2.1 Relevant identified uses
Aerosol sealant
Icons in SDS
Company Information
company name
ITW Permatex
Section 2
SECTION 2: Hazards identification
Toxicity: May cause nose, throat and respiratory irritation. May cause eye and skin irritation. Intentional misuse by concentrating and inhaling the vapor may be harmful or fatal. Excessive inhalation causes headache, dizziness, nausea, and incoordination. Ethyl acetate may cause anemia. Long term exposure to high concentrations of vapor may cause lung, liver or kidney damage. n-Hexane may damage peripheral nerve tissue.
Principle Routes of Exposure
Eye and skin contact, ingestion, inhalation Signs and Symptoms of Exposure: Excessive overexposure may cause giddiness, dizziness, headache, nausea and in extreme cases, unconsciousness and respiratory depression. Inhaling may cause mild irritation to the nose, throat and respiratory tract and may result in central nervous system (CNS) depression. May cause pain, redness or swelling of the eyes and excessive blinking and tear production. Skin: Exposure may cause mild skin irritation. Prolonged or repeated exposure may dry the skin. Symptoms may include redness, burning, drying, cracking and skin burns. Preexisting skin disorders may be aggravated by exposure. . Swallowing: This material can enter the lungs during swallowing or vomiting and cause lung inflammation and/or damage. Aspiration into the lungs can cause chemical pneumonia which can be fatal. Component: Weight% NTP ACGIH Carcinogens IARC Carcinogen ACETONE <5 A4 - Not Classifiable 67-64-1 as a Human Carcinogen
Medical Conditions Generally Aggravated by Exposure
Persons with preexisting respiratory, liver, kidney, eye or skin diseases may be adversely affected.